Cargando…
Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways
Taxifolin is a potent flavonoid that exerts anti-oxidative effect, and cilostazol increases intracellular cAMP levels by inhibiting phosphodiesterase 3 that shows antiinflammatory actions. BACE1 (β-site APP cleaving enzyme 1) is the rate-limiting enzyme responsible for the β-cleavage of amyloid prec...
Autores principales: | Park, So Youn, Kim, Hae Young, Park, Hee Jeong, Shin, Hwa Kyoung, Hong, Ki Whan, Kim, Chi Dae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158044/ https://www.ncbi.nlm.nih.gov/pubmed/27977755 http://dx.doi.org/10.1371/journal.pone.0168286 |
Ejemplares similares
-
Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression
por: Heo, Hye Jin, et al.
Publicado: (2020) -
Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells
por: Park, So Youn, et al.
Publicado: (2016) -
Cilostazol Upregulates Autophagy via SIRT1 Activation: Reducing Amyloid-β Peptide and APP-CTFβ Levels in Neuronal Cells
por: Lee, Hye Rin, et al.
Publicado: (2015) -
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2021) -
Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
por: Kim, Kyu Seop, et al.
Publicado: (2011)